文献速递烧伤

热调节血管内导管在危重烧伤患者中的应用评价

Evaluation of a thermoregulatory intravascular catheter in critically ill burns patients.
PubMed 文献 · J Burn Care Res · 2024-01-01

本研究在三级转诊烧伤中心开展单中心前瞻性评价,18个月内10例危重烧伤患者共置入12根热调节静脉导管(Thermogard XP®),ICU期间体温中位低值36.9°C、中位高值38.4°C;≤50% TBSA患者术中体温中位变化-0.15°C,>50% TBSA患者为-1.45°C;30%患者发生血栓并发症。

要点

  • ICU期间体温维持在中位低值36.9°C至中位高值38.4°C之间。
  • TBSA≤50%患者术中体温中位变化-0.15°C,>50%者为-1.45°C。
  • 30%患者发生血栓并发症,装置总体似能可靠维持正常体温。

核心结论

  • 该装置在实现和维持危重烧伤伴体温调节异常患者的正常体温方面似乎可靠,也可能对术中预期出现体温波动的患者有益。
  • 需要进一步研究以明确该装置是否优于当前实践,并探究此类装置相关的血栓风险。

研究设计与样本

  • 单中心前瞻性评价,在三级转诊烧伤中心ICU对18个月期间收治的危重烧伤患者使用热调节静脉导管系统(Thermogard XP®)。
  • 共10例患者置入12根导管。

主要发现

  • ICU期间患者体温维持在中位低值36.9°C至中位高值38.4°C之间。
  • 若患者转至手术室,TBSA≤50%时体温中位变化为-0.15°C(四分位距[IQR] -0.3,0),TBSA>50%时为-1.45°C(IQR -2.05,-0.975)。
  • 无手术因术中低体温而终止。
  • 从手术室返回时,72.2%患者体温正常,中位体温36.8°C。
  • 30%患者发生血栓并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以明确该装置是否优于当前实践。
  • 需要进一步研究以探究此类装置相关的血栓风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with severe burns are at high risk of thermoregulatory failure. Yet, there is a lack of consensus regarding the optimum approach to temperature dysregulation in patients with severe burns. Intravascular temperature management catheters may offer a superior method of temperature control, but robust data are lacking. In this article, we describe our experience in using a thermoregulatory catheter for temperature management in a tertiary referral burns center. We conducted a single-center, prospective evaluation of the use of a thermoregulatory intravenous catheter system (Thermogard XP®) in critically injured burns patients admitted to our intensive care unit over an 18-month period. Ten patients had a total of 12 catheters inserted. Patient temperatures were maintained between a median low of 36.9 °C and a median high of 38.4 °C while in the intensive care unit. If patients were transferred to theater, the median temperature change was -0.15 °C (interquartile range [IQR] -0.3, 0) if TBSA was ≤50% and -1.45 °C (IQR -2.05, -0.975) if >50%. No surgical procedures were terminated due to intraoperative hypothermia. On return from theater, 72.2% of patients were normothermic with a median temperature of 36.8 °C. Thirty percent of patients developed a thrombotic complication. Overall, the device appeared reliable in achieving and maintaining normothermia for critically ill burns patients manifesting temperature dysregulation. It may also be of benefit to patients expected to show temperature fluctuations during operative procedures. Further research is needed to define whether this represents an improvement over current practice and investigate the thrombus risk associated with such devices.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Brown A, McGovern C, Davidson M, et al. Evaluation of a thermoregulatory intravascular catheter in critically ill burns patients. J Burn Care Res. 2024. PMID: 38236005. doi:10.1093/jbcr/irae006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。